Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Gains from Sales and Divestitures (2017 - 2024)

Historic Gains from Sales and Divestitures for Chemours (CC) over the last 8 years, with Q4 2024 value amounting to $343000.0.

  • Chemours' Gains from Sales and Divestitures fell 1634.15% to $343000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $343000.0, marking a year-over-year decrease of 1634.15%. This contributed to the annual value of $343000.0 for FY2024, which is 1634.15% down from last year.
  • As of Q4 2024, Chemours' Gains from Sales and Divestitures stood at $343000.0, which was down 1634.15% from $410000.0 recorded in Q4 2023.
  • In the past 5 years, Chemours' Gains from Sales and Divestitures registered a high of $473000.0 during Q4 2022, and its lowest value of $176000.0 during Q4 2020.
  • In the last 5 years, Chemours' Gains from Sales and Divestitures had a median value of $343000.0 in 2024 and averaged $318000.0.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first tumbled by 8842.11% in 2020, then skyrocketed by 15159.57% in 2022.
  • Chemours' Gains from Sales and Divestitures (Quarter) stood at $176000.0 in 2020, then increased by 6.82% to $188000.0 in 2021, then skyrocketed by 151.6% to $473000.0 in 2022, then dropped by 13.32% to $410000.0 in 2023, then dropped by 16.34% to $343000.0 in 2024.
  • Its last three reported values are $343000.0 in Q4 2024, $410000.0 for Q4 2023, and $473000.0 during Q4 2022.